Lifevantage Corporation (LFVN): Price and Financial Metrics
Lifevantage Corporation (LFVN)
Today's Latest Price: $11.87 USD
Updated Oct 22 4:00pm
Add LFVN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 14 in Medical - Consumer Goods
See all "A" rated Strong Buy stocks
LFVN Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for LFVN is 7 -- better than 94.76% of US stocks.
- Of note is the ratio of Lifevantage Corp's sales and general administrative expense to its total operating expenses; 87.82% of US stocks have a lower such ratio.
- For LFVN, its debt to operating expenses ratio is greater than that reported by merely 4.48% of US equities we're observing.
- If you're looking for stocks that are quantitatively similar to Lifevantage Corp, a group of peers worth examining would be JYNT, SITE, CTG, GNE, and RVLV.
- LFVN's SEC filings can be seen here. And to visit Lifevantage Corp's official web site, go to www.lifevantage.com.
LFVN Stock Price Chart Interactive Chart >
LFVN Price/Volume Stats
| Current price | $11.87 | 52-week high | $17.25 |
| Prev. close | $12.04 | 52-week low | $7.75 |
| Day low | $11.85 | Volume | 42,400 |
| Day high | $12.32 | Avg. volume | 87,448 |
| 50-day MA | $13.37 | Dividend yield | N/A |
| 200-day MA | $13.56 | Market Cap | 169.05M |
Lifevantage Corporation (LFVN) Company Bio
LifeVantage Corporation identifies, researches, develops, and distributes nutraceutical dietary supplements and skin care products. The company is based in Sandy, Utah.
LFVN Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $11.87 | $11.04 | -8% |
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Lifevantage Corp. To summarize, we found that Lifevantage Corp ranked in the 45th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of Lifevantage Corp, consider:
- The company has produced more trailing twelve month cash flow than merely 11.46% of its sector Consumer Defensive.
- The business' balance sheet suggests that 1% of the company's capital is sourced from debt; this is greater than merely 4.27% of the free cash flow producing stocks we're observing.
- LFVN's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 56.29% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -10% |
| 1% | -9% |
| 2% | -8% |
| 3% | -8% |
| 4% | -7% |
| 5% | -6% |
Want more companies with a valuation profile/forecast similar to that of Lifevantage Corp? See POST, NWL, CPB, BUD, and FIZZ.
Loading social stream, please wait...